identified TCF1+ PD‐1+ cells in both the blood and TILs of melanoma patients, which display characteristics of both exhausted and central memory T (Tcm) cells and mediate the proliferative response to immunotherapy.[105] Yamauchi et al. This evidence concerns the gene PDCD1 and melanoma.